Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer.

Chaube, Udit; Dey, Rajdeep; Shaw, Suman; Patel, Bhumika D; Bhatt, Hardik G

Chaube, Udit; Dey, Rajdeep; Shaw, Suman; Patel, Bhumika D; Bhatt, Hardik G.

Afiliación

Chaube U; Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382481, India.
Dey R; Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382481, India.
Shaw S; Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382481, India.
Patel BD; Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382481, India.
Bhatt HG; Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382481, India.

Future Med Chem ; 14(23): 1789-1809, 2022 12.

Article en En | MEDLINE | ID: mdl-36538021

Asunto(s)

Neoplasias Pulmonares; Quinolinas; Humanos; Inhibidores mTOR; Neoplasias Pulmonares/tratamiento farmacológico; Quinolinas/farmacología; Quinolinas/uso terapéutico; Inhibidores de Proteínas Quinasas/farmacología; Inhibidores de Proteínas Quinasas/uso terapéutico; Serina-Treonina Quinasas TOR

Palabras clave

lung cancer; mTOR; mTOR inhibitors; rapalogs; tetrahydroquinoline

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinolinas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Future Med Chem Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google